Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue MMX for improved detection of nonpolypoid colorectal neoplasms during colonoscopy
ChiCTR2400092612Phase 3Completed
- Sponsor
- Beijing Friendship Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lumeblue in colorectal neoplasm (2 arms), sponsored by Beijing Friendship Hospital. Primary endpoint: Detection rate of nonpolypoid colorectal neoplasms. Started Nov 2024; status: completed.
02
Drugs
lumeblue
03
Conditions
colorectal neoplasm
Beyond the preview
Go deeper on ChiCTR2400092612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092612.